← Back to Search

Goals of Care Conversations Training for Seriously Ill Patients (LSTDI Trial)

N/A
Waitlist Available
Led By David Bekelman, MD MPH
Research Sponsored by VA Office of Research and Development
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Diagnosis of cancer, heart failure, interstitial lung disease, chronic obstructive pulmonary disease, end-stage renal disease, end-stage liver disease, and dementia
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up from the start of stage 1 to 9 months after the start of stage 2
Awards & highlights

LSTDI Trial Summary

This trial is testing ways to help Veterans express their preferences for life-sustaining treatments, so that their wishes can be honored.

Who is the study for?
This trial is for Veterans with serious illnesses like cancer, heart failure, lung diseases, kidney or liver failure, and dementia. They must be enrolled in VHA healthcare at one of the study sites and have a high risk of hospitalization or death within a year. Clinicians eligible are those who need to improve their skills in discussing care goals with patients.Check my eligibility
What is being tested?
The study tests different strategies to help clinicians engage in early conversations about care goals with seriously ill patients. It involves two stages: low intensity training followed by high intensity training for clinicians, paired with varying levels of patient engagement.See study design
What are the potential side effects?
Since this trial focuses on communication strategies rather than medical treatments, there are no direct physical side effects. However, discussions about end-of-life care can be emotionally impactful for both patients and caregivers.

LSTDI Trial Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I have been diagnosed with a serious condition like cancer, heart failure, or dementia.

LSTDI Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~from the start of stage 1 to 9 months after the start of stage 2
This trial's timeline: 3 weeks for screening, Varies for treatment, and from the start of stage 1 to 9 months after the start of stage 2 for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Percent of patients with a goals of care conversation note documented in Stage 2
Secondary outcome measures
Percent of patients with a goals of care conversation note documented in Stage 1
Percent of patients with a goals of care conversation note documented in Stage 1 or 2

LSTDI Trial Design

4Treatment groups
Active Control
Group I: Low then high patient engagementActive Control4 Interventions
First stage: Low intensity patient engagement. Low intensity clinician training. Second stage (responders only): No patient engagement and high intensity clinician training. Second stage (non-responders only): High patient engagement and high intensity clinician training.
Group II: No then low patient engagementActive Control3 Interventions
First stage: No patient engagement. Low intensity clinician training. Second stage (responders only): No patient engagement and high intensity clinician training. Second stage (non-responders only): Low intensity patient engagement and high intensity clinician training.
Group III: Low then low patient engagementActive Control3 Interventions
First stage: Low patient engagement. Low intensity clinician training. Second stage (responders only): No patient engagement and high intensity clinician training. Second stage (non-responders only): Low intensity patient engagement and high intensity clinician training.
Group IV: No then high patient engagementActive Control3 Interventions
First stage: No patient engagement. Low intensity clinician training. Second stage (responders only): No patient engagement and high intensity clinician training. Second stage (non-responders only): High patient engagement and high intensity clinician training.

Find a Location

Who is running the clinical trial?

VA Office of Research and DevelopmentLead Sponsor
1,609 Previous Clinical Trials
3,306,531 Total Patients Enrolled
David Bekelman, MD MPHPrincipal InvestigatorRocky Mountain Regional VA Medical Center, Aurora, CO
2 Previous Clinical Trials
331 Total Patients Enrolled
Anne M Walling, MD PhDPrincipal InvestigatorVA Greater Los Angeles Healthcare System, West Los Angeles, CA

Media Library

Low then high patient engagement Clinical Trial Eligibility Overview. Trial Name: NCT05001009 — N/A
Seriously Ill Patients Research Study Groups: Low then high patient engagement, No then low patient engagement, Low then low patient engagement, No then high patient engagement
Seriously Ill Patients Clinical Trial 2023: Low then high patient engagement Highlights & Side Effects. Trial Name: NCT05001009 — N/A
Low then high patient engagement 2023 Treatment Timeline for Medical Study. Trial Name: NCT05001009 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Does this research endeavor still have openings for participants?

"Clinicaltrials.gov records indicate that, as of October 6th 2022, this clinical trial is no longer recruiting new patients. Originally posted on September 13th 20202, the study has been concluded and there are currently 2455 additional medical studies actively looking for participants."

Answered by AI

Who else is applying?

What state do they live in?
Colorado
Ohio
California
Other
How old are they?
18 - 65
65+
What portion of applicants met pre-screening criteria?
Met criteria
Did not meet criteria
What site did they apply to?
VA Greater Los Angeles Healthcare System, West Los Angeles, CA
Recent research and studies
clinicaltrials.govStudy
Goals of Care Conversations Study
2022. "Goals of Care Conversations Study". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT05001009.
All > Lung Disease > Heart Failure
~15 spots leftby Sep 2024
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top